Nanomedicine
Infectious Diseases, Immunotherapy, Diagnostics, Antifibrotics, Toxicology and Gene Medicine Volume 509
Herausgegeben:Duzgunes, Nejat
Nanomedicine
Infectious Diseases, Immunotherapy, Diagnostics, Antifibrotics, Toxicology and Gene Medicine Volume 509
Herausgegeben:Duzgunes, Nejat
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This volume in the Methods in Enzymology series comprehensively covers Infectious Diseases, Immunotheraphy, Gene Medicine, Diagnostics and Toxicology of Nanomedicine. With an international board of authors, this volume is split into sections that cover subjects such as Nanomedicines in Immunotherapy, Nanomedicine toxicity, and Diagnostic Nanomedicine.
Andere Kunden interessierten sich auch für
Cancer Theranostics179,99 €
Nanomedicine137,99 €
Neurotoxicity of Nanomaterials and Nanomedicine96,99 €
Patrick ArbuthnotGene Therapy for Viral Infections96,99 €
Nanoscience in Dermatology108,99 €
Jacques FantiniBrain Lipids in Synaptic Function and Neurological Disease81,99 €
Clemens van BlitterswijkTissue Engineering128,99 €-
-
-
This volume in the Methods in Enzymology series comprehensively covers Infectious Diseases, Immunotheraphy, Gene Medicine, Diagnostics and Toxicology of Nanomedicine. With an international board of authors, this volume is split into sections that cover subjects such as Nanomedicines in Immunotherapy, Nanomedicine toxicity, and Diagnostic Nanomedicine.
Produktdetails
- Produktdetails
- Methods in Enzymology Volume 509
- Verlag: Academic Press
- Artikelnr. des Verlages: C2011-0-04217-5
- Seitenzahl: 470
- Erscheinungstermin: 23. Mai 2012
- Englisch
- Abmessung: 240mm x 159mm x 32mm
- Gewicht: 900g
- ISBN-13: 9780123918581
- ISBN-10: 0123918588
- Artikelnr.: 35503688
- Herstellerkennzeichnung
- Elsevier LTD
- 125 London Wall
- EC2Y 5AS London, GB
- germany.elsevier.com
- 0044 1865844645
- Methods in Enzymology Volume 509
- Verlag: Academic Press
- Artikelnr. des Verlages: C2011-0-04217-5
- Seitenzahl: 470
- Erscheinungstermin: 23. Mai 2012
- Englisch
- Abmessung: 240mm x 159mm x 32mm
- Gewicht: 900g
- ISBN-13: 9780123918581
- ISBN-10: 0123918588
- Artikelnr.: 35503688
- Herstellerkennzeichnung
- Elsevier LTD
- 125 London Wall
- EC2Y 5AS London, GB
- germany.elsevier.com
- 0044 1865844645
Antiviral Nanomedicines
- Enhanced antiviral activity of acyclovir loaded into nanoparticles
- Gold manno-Glyconanoparticles for Intervening in HIV gp120 Carbohydrate-Mediated Processes
- Nanoparticle mediated targeted delivery of antiretrovirals to the brain
- Antibacterial activity of doxycycline-loaded nanoparticles
- Antimicrobial properties of electrically formed elastomeric polyurethane-copper oxide nanocomposites for medical and dental applications
- Gastrointestinal delivery of anti-inflammatory nanoparticles
- Chitosan-based nanoparticles as a Hepatitis B antigen delivery system
- Targeting nanoparticles to dendritic cells for immunotherapy
- Design and fabrication of N-Alkyl-polyethylenimine stabilized iron oxide nanoclusters for gene delivery
- Protein-Carbon Nanotube Sensors: Single Platform Integrated Micro Clinical Lab for Monitoring Blood Analytes
- Investigating the toxic effects of iron oxide nanoparticles
- Cytotoxicity of Gold Nanoparticles
- Design of target-seeking antifibrotic compounds
- Cell-penetrating peptide-based systems for nucleic acid delivery: A biological and biophysical approach
- Multifunctional envelope-type nano-device (MEND) for organelle targeting via a step-wise membrane fusion process
- Lipopolyplexes as nanomedicines for therapeutic gene delivery
- Interfering nanoparticles (iNOPs) for silencing microRNAs
- Genetic Nanomedicine: Gene Delivery by Targeted Lipoplexes
Antibacterial Nanomedicines
Nanomedicines in Immunotherapy
Diagnostic Nanomedicine
Nanomedicine Toxicity
Antifibrotic Nanomedicine
Genetic Nanomedicine
Antiviral Nanomedicines
- Enhanced antiviral activity of acyclovir loaded into nanoparticles
- Gold manno-Glyconanoparticles for Intervening in HIV gp120 Carbohydrate-Mediated Processes
- Nanoparticle mediated targeted delivery of antiretrovirals to the brain
- Antibacterial activity of doxycycline-loaded nanoparticles
- Antimicrobial properties of electrically formed elastomeric polyurethane-copper oxide nanocomposites for medical and dental applications
- Gastrointestinal delivery of anti-inflammatory nanoparticles
- Chitosan-based nanoparticles as a Hepatitis B antigen delivery system
- Targeting nanoparticles to dendritic cells for immunotherapy
- Design and fabrication of N-Alkyl-polyethylenimine stabilized iron oxide nanoclusters for gene delivery
- Protein-Carbon Nanotube Sensors: Single Platform Integrated Micro Clinical Lab for Monitoring Blood Analytes
- Investigating the toxic effects of iron oxide nanoparticles
- Cytotoxicity of Gold Nanoparticles
- Design of target-seeking antifibrotic compounds
- Cell-penetrating peptide-based systems for nucleic acid delivery: A biological and biophysical approach
- Multifunctional envelope-type nano-device (MEND) for organelle targeting via a step-wise membrane fusion process
- Lipopolyplexes as nanomedicines for therapeutic gene delivery
- Interfering nanoparticles (iNOPs) for silencing microRNAs
- Genetic Nanomedicine: Gene Delivery by Targeted Lipoplexes
Antibacterial Nanomedicines
Nanomedicines in Immunotherapy
Diagnostic Nanomedicine
Nanomedicine Toxicity
Antifibrotic Nanomedicine
Genetic Nanomedicine







